Author | Noah S. Kornblum, MD | OncLive

Author | Noah S. Kornblum, MD

Articles

Dr. Kornblum on Results of PrECOG 0102 in Breast Cancer

March 06, 2017

Video

Noah S. Kornblum, MD, assistant professor of medicine, Albert Einstein College of Medicine, attending physician of medicine, Montefiore-Einstein Center for Cancer Care, discusses the results from the PrECOG 0102 study, which explored the addition of everolimus (Afinitor) to fulvestrant (Faslodex) as a treatment for patients with metastatic hormone receptor (HR)–positive, HER2-negative breast cancer.

Dr. Kornblum on Impact of PrECOG 0102 Trial for HR+/HER2- Breast Cancer

December 08, 2016

Video

Noah S. Kornblum, MD, assistant professor of medicine, Albert Einstein College of Medicine, and attending physician of medicine, Montefiore-Einstein Center for Cancer Care, discusses the phase II PrECOG 0102 trial, which explored the addition of everolimus (Afinitor) to fulvestrant (Faslodex) as a treatment for patients with metastatic hormone receptor (HR)–positive, HER2-negative breast cancer.

x